An initial step toward symptom-based pharmacotherapy for borderline personality disorder: a systematic review and meta-analysis
Abstract Background Although no pharmacological treatments have received regulatory approval for borderline personality disorder (BPD), antipsychotic medications—particularly haloperidol, olanzapine, and risperidone—are frequently prescribed off-label in clinical practice. This study aims to quantit...
Saved in:
| Main Authors: | Ramin Abdi Dezfouli, Soroush Hashemzadeh, Moloud Saleh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-08-01
|
| Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41983-025-01011-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review
by: Alessandro Pascucci, et al.
Published: (2025-07-01) -
Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients
by: Takashi Kusunoki, et al.
Published: (2025-05-01) -
Haloperidol versus second-generation antipsychotics on the cognitive performance of individuals with schizophrenia and related disorders: pairwise meta-analysis of randomized controlled trials
by: Daniel Prates Baldez, et al.
Published: (2025-05-01) -
A cross-sectional study to analyze the pattern of pharmacotherapy and its associated factors among patients with schizophrenia
by: B. S. Abhishree, et al.
Published: (2024-12-01) -
Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone
by: M. V. Belova, et al.
Published: (2020-10-01)